Jean-Baptiste Vulsteke
@jbvulsteke.bsky.social
MD PhD | Systemic autoimmune diseases & autoantibodies | Rheumatologist in AZ Delta Roeselare and UZ Leuven 🇧🇪
The TFIID complex is a new autoantibody target in #systemicsclerosis.
Read about it in ARD ⬇️
ard.eular.org/article/S000...
Read about it in ARD ⬇️
ard.eular.org/article/S000...
The TFIID complex is a new autoantibody target in systemic sclerosis
Systemic sclerosis (SSc) is characterised by systemic fibrosis, vascular dysfunction,
and the presence of antinuclear autoantibodies. The major SSc-associated antinuclear
antibodies include anticentro...
ard.eular.org
June 29, 2025 at 12:27 PM
The TFIID complex is a new autoantibody target in #systemicsclerosis.
Read about it in ARD ⬇️
ard.eular.org/article/S000...
Read about it in ARD ⬇️
ard.eular.org/article/S000...
A new addition to the ABC of autoantigens in #systemicsclerosis: ABCE1
➡️ 1 patient with severe SSc-ILD
2️⃣ Second cytoplasmic autoantigen in SSc (after eIF2B)
Read all about it in our Correspondence in Autoimmunity Reviews ⬇️
www.sciencedirect.com/science/arti...
➡️ 1 patient with severe SSc-ILD
2️⃣ Second cytoplasmic autoantigen in SSc (after eIF2B)
Read all about it in our Correspondence in Autoimmunity Reviews ⬇️
www.sciencedirect.com/science/arti...
www.sciencedirect.com
February 17, 2025 at 10:44 AM
A new addition to the ABC of autoantigens in #systemicsclerosis: ABCE1
➡️ 1 patient with severe SSc-ILD
2️⃣ Second cytoplasmic autoantigen in SSc (after eIF2B)
Read all about it in our Correspondence in Autoimmunity Reviews ⬇️
www.sciencedirect.com/science/arti...
➡️ 1 patient with severe SSc-ILD
2️⃣ Second cytoplasmic autoantigen in SSc (after eIF2B)
Read all about it in our Correspondence in Autoimmunity Reviews ⬇️
www.sciencedirect.com/science/arti...